GA successfully reduced the VEGF levels in tumor cells at a dose of 80 mg/kg (p ≤ 0.001) and in ascites fluid at both doses (p ≤ 0.05) as compared to the saline-treated control group, whereas CA reduced the VEGF levels but without statistical significance. The gene discussed is VEGFA; the disease is neoplasm.